Floatz logo

LEUPROLIDE

Hormone Deficiency

Pennington Biomedical Research Centerprotein_peptideDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Hormone Deficiency cohort.

Asset / SponsorPhaseRating
Genotropin
Max-Planck-Institute of Psychiatry
Phase 2CCC
Testosterone Undecannoate
Max-Planck-Institute of Psychiatry
Phase 2CCC
Gly-Low
Hoskinson Health and Wellness Clinic
Early Phase 1CC
AE-PEANUT
Al-Balqa Applied University
N/AD

Same molecule, other indications

LEUPROLIDE is also rated in:

prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →